$24.99
Value $530M
NRC and UNH stock compared: price, dividend, valuation and results, from SEC filings.
$24.99
Value $530M
$330.48
Value $300B
NRC Health (NRC) has a market value of $530M and UnitedHealth (UNH) $300B. Over the last year, with dividends, NRC moved +61.0% and UNH +8.2%. The P/E is 86.5 for NRC and 18.9 for UNH. Dividend yield: NRC 2.56%, UNH 2.74%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
NRC$530M
UNH$300B
UNH is 566 times NRC
Revenue, 12 months
NRC$144M
UNH$450B
UNH is 3,127 times NRC
Net income, 12 months
NRC$6.1M
UNH$15.9B
UNH is 2,590 times NRC
Operating margin
NRC11.1%
UNH5.3%
5.8 points apart
ROIC
NRC10.4%
UNH11.3%
0.9 points apart
P/E
NRC86.5
UNH18.9
NRC is 4.6 times UNH
Dividend yield
NRC2.6%
UNH2.7%
0.1 points apart
5-year return
NRC-35.1%
UNH-19.5%
15.6 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
NRC-35.1%
UNH-19.5%
| Period | NRCWith dividends | UNHWith dividends |
|---|---|---|
| 1 year since November 18, 2025 | +61.0%Price +55.7% | +8.2%Price +5.4% |
| 3 years since November 17, 2023 | -34.2%-13.0% a yearPrice -39.4% | -34.4%-13.1% a yearPrice -38.4% |
| 5 years since November 18, 2021 | -35.1%-8.3% a yearPrice -43.4% | -19.5%-4.2% a yearPrice -26.5% |
| 10 years since November 21, 2016 | +94.6%+6.9% a yearPrice +57.2% | +159.4%+10.0% a yearPrice +119.7% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
NRCNRC HealthUNHUnitedHealth
| Price | $24.99 | $330.48 |
|---|---|---|
| Market value | $530M | $300B |
| Enterprise value (EV) | $630M | $346B |
| P/E | 86.5 | 18.9 |
| P/E, 5-year median | 28.4 | 25.0 |
| P/B | – | 2.9 |
| EV/EBIT | 39.6 | 14.5 |
| Free cash flow yield | 3.5% | 7.6% |
| Revenue, 12 months | $144M | $450B |
|---|---|---|
| Net income, 12 months | $6.1M | $15.9B |
| Free cash flow, 12 months | $18M | $22.8B |
| Earnings per share, 12 months | $0.27 | $17.52 |
| Revenue growth, year on year | -4.0% | 11.8% |
| Revenue growth a year, past | +0.6%over 5 years | +11.7%over 5 years |
| EPS growth a year, past | +103.0%over 5 years | -3.8%over 5 years |
| Gross margin | – | 88.3% |
|---|---|---|
| Operating margin | 11.1% | 5.3% |
| Net margin | 4.3% | 3.5% |
| ROIC | 10.4% | 11.3% |
| ROE | 78.2% | 15.5% |
| Cash | $3.6M | $28.5B |
|---|---|---|
| Total debt | $103M | $74.3B |
| Net debt / EBITDA | 4.2 | 1.6 |
| Interest cover | 2.9× | 6.2× |
| Dividend yield | 2.6% | 2.7% |
|---|---|---|
| Dividend per share, 12 months | $0.64 | $9.06 |
| Dividend growth a year, past | – | +12.6%over 5 years |
| Buyback yield | 3.8% | 1.8% |
| Shareholder yield | 6.4% | 4.6% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, UnitedHealth ($300B) is about 565.6 times NRC Health ($530M), at today's prices.
Since November 21, 2016, NRC's price moved +57.2% and UNH's +119.7%. With dividends: NRC +94.6% (+6.9% a year), UNH +159.4% (+10.0% a year). Past returns do not predict future ones.
The dividend yield at today's price is 2.56% for NRC Health and 2.74% for UnitedHealth. Over the last twelve months they paid $0.64 and $9.06 per share.
At today's price, the P/E is 86.5 for NRC and 18.9 for UNH. The median of the last five years was 28.4 and 25.0, which shows where each stands against its own past.
Over the last twelve months, the net margin was 4.3% for NRC Health and 3.5% for UnitedHealth, and the operating margin 11.1% and 5.3%. Revenue was $144M and $450B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.